Pricing limits could lead the companies producing COVID-19 drugs to walk away,
according to Anthony Fauci, MD, director of the National Institute of
Allergy and Infectious Diseases in the National Institutes of Health.
Dr. Fauci discouraged the federal government from forcing drugmakers
to lower the costs of COVID-19 vaccines and treatments at BIO Digital, a
virtual convention held on June 8. However, he recognized that the
pandemic has widely affected regions that cannot afford expensive
interventions. He encouraged the government to advocate for fair
pricing, but to be wary about passing legislation that would impose
price ceilings.
“One thing that is clear is that if you try to enforce things on a
company that has multiple, different opportunities to do different
things, they will walk away,” Dr. Fauci said at BIO Digital. “I’ve never
seen a successful attempt at doing controls.”
Dr. Fauci’s comments come as multiple drug pricing plan proposals
have been introduced to Congress, most notably from House Speaker Nancy
Pelosi, D-Calif., and Sen. Elizabeth Warren, D-Mass.
https://www.beckershospitalreview.com/pharmacy/i-ve-never-seen-a-successful-attempt-at-doing-controls-fauci-warns-against-pricing-limits.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.